Published in Anal Chem on April 16, 2012
Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther (2005) 6.04
A secreted luciferase for ex vivo monitoring of in vivo processes. Nat Methods (2008) 3.31
Mycoplasma infection of cultured cells. Nature (1989) 2.42
Mycoplasma contamination of cell cultures: Incidence, sources, effects, detection, elimination, prevention. Cytotechnology (2002) 1.80
Beware of mycoplasmas. Trends Biotechnol (1993) 1.60
Persistent exposure to Mycoplasma induces malignant transformation of human prostate cells. PLoS One (2009) 1.57
High-throughput detection and multiplex identification of cell contaminations. Nucleic Acids Res (2009) 1.49
Gaussia luciferase variant for high-throughput functional screening applications. Anal Chem (2009) 1.35
Detection of Mycoplasma in cell cultures. Nat Protoc (2010) 1.33
Rapid and simple identification of mycoplasmas by immunobinding. J Immunol Methods (1985) 1.30
Detection of mycoplasma in leukemia-lymphoma cell lines using polymerase chain reaction. Leukemia (2002) 1.23
Mycoplasma infection suppresses p53, activates NF-kappaB and cooperates with oncogenic Ras in rodent fibroblast transformation. Oncogene (2008) 1.20
Mycoplasma fermentans infection promotes immortalization of human peripheral blood mononuclear cells in culture. Blood (2004) 0.98
Mycoplasma contamination revisited: mesenchymal stromal cells harboring Mycoplasma hyorhinis potently inhibit lymphocyte proliferation in vitro. PLoS One (2011) 0.84
Detection of mycoplasmas in cell cultures by fluorescence methods. Methods Mol Biol (1998) 0.79
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
A secreted luciferase for ex vivo monitoring of in vivo processes. Nat Methods (2008) 3.31
A highly sensitive assay for monitoring the secretory pathway and ER stress. PLoS One (2007) 2.63
miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell (2008) 2.57
Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation: clinical and genetic characterization and target for therapy. Brain (2014) 2.14
Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway. Mol Cell Biol (2009) 2.06
Human glioma growth is controlled by microRNA-10b. Cancer Res (2011) 1.96
In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma. Cancer Cell (2010) 1.94
Performance of the red-shifted fluorescent proteins in deep-tissue molecular imaging applications. J Biomed Opt (2008) 1.93
miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis. Oncotarget (2010) 1.92
Bioluminescence imaging: progress and applications. Trends Biotechnol (2011) 1.59
Microvesicle-associated AAV vector as a novel gene delivery system. Mol Ther (2012) 1.49
BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles. Mol Ther Nucleic Acids (2013) 1.40
Secreted Gaussia luciferase as a biomarker for monitoring tumor progression and treatment response of systemic metastases. PLoS One (2009) 1.37
Gaussia luciferase variant for high-throughput functional screening applications. Anal Chem (2009) 1.35
siRNA knock-down of mutant torsinA restores processing through secretory pathway in DYT1 dystonia cells. Hum Mol Genet (2008) 1.15
Real-time monitoring of nuclear factor kappaB activity in cultured cells and in animal models. Mol Imaging (2009) 1.13
Multimodal in vivo imaging and blood monitoring of intrinsic and extrinsic apoptosis. Mol Ther (2011) 1.11
Heparin blocks transfer of extracellular vesicles between donor and recipient cells. J Neurooncol (2013) 1.09
Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases. Proc Natl Acad Sci U S A (2012) 1.09
Down-regulation of miR-101 in endothelial cells promotes blood vessel formation through reduced repression of EZH2. PLoS One (2011) 1.07
In-vivo imaging of murine tumors using complete-angle projection fluorescence molecular tomography. J Biomed Opt (2009) 1.05
Lanatoside C sensitizes glioblastoma cells to tumor necrosis factor-related apoptosis-inducing ligand and induces an alternative cell death pathway. Neuro Oncol (2011) 1.02
Functional drug screening assay reveals potential glioma therapeutics. Assay Drug Dev Technol (2010) 1.01
In vivo tomographic imaging of red-shifted fluorescent proteins. Biomed Opt Express (2011) 1.00
Glioma angiogenesis: Towards novel RNA therapeutics. Cell Adh Migr (2009) 0.98
Triple bioluminescence imaging for in vivo monitoring of cellular processes. Mol Ther Nucleic Acids (2013) 0.96
EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma. Oncotarget (2014) 0.96
Binding of estrogen receptor beta to estrogen response element in situ is independent of estradiol and impaired by its amino terminus. Mol Endocrinol (2005) 0.95
Single reporter for targeted multimodal in vivo imaging. J Am Chem Soc (2012) 0.94
The acid test of fluoride: how pH modulates toxicity. PLoS One (2010) 0.93
A water-soluble coelenterazine for sensitive in vivo imaging of coelenterate luciferases. Mol Ther (2012) 0.91
Mouse gender influences brain transduction by intravascularly administered AAV9. Mol Ther (2013) 0.89
Targeting cancer cells with the natural compound obtusaquinone. J Natl Cancer Inst (2013) 0.89
Valproic acid enhances gene expression from viral gene transfer vectors. J Virol Methods (2005) 0.88
Enhanced in vivo imaging of metabolically biotinylated cell surface reporters. Anal Chem (2011) 0.88
Extracellular vesicles and intercellular communication within the nervous system. J Clin Invest (2016) 0.87
Systemic anticancer neural stem cells in combination with a cardiac glycoside for glioblastoma therapy. Stem Cells (2014) 0.87
Directed molecular evolution reveals Gaussia luciferase variants with enhanced light output stability. Anal Chem (2013) 0.84
Functional multiplex reporter assay using tagged Gaussia luciferase. Sci Rep (2013) 0.83
Advances in stem cell therapy against gliomas. Trends Mol Med (2013) 0.82
Simultaneous in vivo monitoring of regulatory and effector T lymphocytes using secreted Gaussia luciferase, Firefly luciferase, and secreted alkaline phosphatase. Methods Mol Biol (2014) 0.82
Attenuated AMPA receptor expression allows glioblastoma cell survival in glutamate-rich environment. PLoS One (2009) 0.82
Enhanced Gaussia luciferase blood assay for monitoring of in vivo biological processes. Anal Chem (2011) 0.82
Noninvasive in vivo monitoring of extracellular vesicles. Methods Mol Biol (2014) 0.81
Extracellular vesicles as enhancers of virus vector-mediated gene delivery. Hum Gene Ther (2014) 0.80
Measurement of fluoride-induced endoplasmic reticulum stress using Gaussia luciferase. Methods Enzymol (2011) 0.78
Codon-optimized Luciola italica luciferase variants for mammalian gene expression in culture and in vivo. Mol Imaging (2012) 0.78
Cell-based immunotherapy against gliomas: from bench to bedside. Mol Ther (2013) 0.78
Activation of adenosine A2A receptor protects sympathetic neurons against nerve growth factor withdrawal. J Neurosci Res (2004) 0.78
Gaussia luciferase-based mycoplasma detection assay in mammalian cell culture. Methods Mol Biol (2014) 0.77
HSV-1 amplicon vectors elicit polyfunctional T cell responses to HIV-1 Env, and strongly boost responses to an adenovirus prime. Vaccine (2007) 0.77
Multiplex blood reporters for simultaneous monitoring of cellular processes. Anal Chem (2013) 0.75
Enhanced transduction of dendritic cells by FcgammaRI-targeted adenovirus vectors. J Gene Med (2007) 0.75
Integrated Kidney Exosome Analysis (iKEA) For The Detection Of Kidney Transplant Rejection. ACS Nano (2017) 0.75